29 / 40
AFLAC U.S.
Aflac Cancer and Blood Disorders Center
The team at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta is committed to providing
a brighter future for children fighting cancer and blood disorders by continuing to deliver advanced medical treatment,
family-centered care, a child-friendly environment and innovative research. The Aflac Cancer Center is a national leader
among childhood cancer, hematology, and blood and marrow transplant programs, serving infants through young adults
and giving children like
Veronica Mata,
11, the opportunity to receive world class care.
Since January 2013, Aflac has participated in the
TOMODACHI Initiative.
Junjiro Ohshima, M.D.
,
assistant professor, HokkaidoUniversityHospital
in Japan, is the second participant in a series of
Japan-based pediatric cancer specialists invited
to the Aflac Cancer and Blood Disorders Center
of Children’s Healthcare of Atlanta through the
TOMODACHI-Aflac Program to observe and
share best practices related to research, care
and treatment protocols of children with cancer.
Aflac is proud to be a part of the TOMODACHI
Initiative and its specific involvement in the area
of pediatric cancer research and treatment. The
TOMODACHI Initiative is a public and private
partnership that invests in the next generation
of Japanese and American citizens in meaningful
disciplinesthatstrengthensrelationshipsbetween
the United States and Japan over the long term.
27
AFLAC U.S. DISTRIBUTION
DISTRIBUTION CHANNEL EMPLOYEE MARKET SEGMENT
PRODUCTS
ENROLLMENT CONDITIONS
Career Agent
< 100
Individual
Face to Face
Self-Service
Broker
100 – 1,000
Individual
Group
Agent Assisted
Self-Service
Call Center
> 1,000
Custom Group
(
Left to right
)
Junjiro Ohshima, M.D.
,
Veronica Mata
,
William G. Woods, M.D.
and
Ansley Riedel